|
FR2492382A1
(fr)
*
|
1980-10-22 |
1982-04-23 |
Synthelabo |
Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
|
|
US4405647A
(en)
*
|
1981-06-15 |
1983-09-20 |
Wm. Wrigley Jr. Company |
Method of compacting chewing gum base
|
|
US5288498A
(en)
*
|
1985-05-01 |
1994-02-22 |
University Of Utah Research Foundation |
Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
|
|
US4863737A
(en)
*
|
1985-05-01 |
1989-09-05 |
University Of Utah |
Compositions and methods of manufacture of compressed powder medicaments
|
|
US5855908A
(en)
*
|
1984-05-01 |
1999-01-05 |
University Of Utah Research Foundation |
Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
|
|
US5132114A
(en)
*
|
1985-05-01 |
1992-07-21 |
University Of Utah Research Foundation |
Compositions and methods of manufacture of compressed powder medicaments
|
|
US5288497A
(en)
*
|
1985-05-01 |
1994-02-22 |
The University Of Utah |
Compositions of oral dissolvable medicaments
|
|
US5785989A
(en)
*
|
1985-05-01 |
1998-07-28 |
University Utah Research Foundation |
Compositions and methods of manufacturing of oral dissolvable medicaments
|
|
FR2606410B1
(fr)
*
|
1986-11-07 |
1989-02-24 |
Synthelabo |
Imidazopyridines, leur preparation et leur application en therapeutique
|
|
US5719197A
(en)
*
|
1988-03-04 |
1998-02-17 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
|
US5223264A
(en)
*
|
1989-10-02 |
1993-06-29 |
Cima Labs, Inc. |
Pediatric effervescent dosage form
|
|
US5178878A
(en)
*
|
1989-10-02 |
1993-01-12 |
Cima Labs, Inc. |
Effervescent dosage form with microparticles
|
|
US5284659A
(en)
|
1990-03-30 |
1994-02-08 |
Cherukuri Subraman R |
Encapsulated flavor with bioadhesive character in pressed mints and confections
|
|
US5686094A
(en)
*
|
1991-04-01 |
1997-11-11 |
Theratech, Inc. |
Controlled release formulations for the treatment of xerostomia
|
|
DE4112652A1
(de)
*
|
1991-04-18 |
1992-10-22 |
Wolman Gmbh Dr |
Holzschutzmittel
|
|
US5786357A
(en)
*
|
1991-12-02 |
1998-07-28 |
Sepracor Inc. |
Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
|
|
TW370529B
(en)
*
|
1992-12-17 |
1999-09-21 |
Pfizer |
Pyrazolopyrimidines
|
|
US6005109A
(en)
|
1997-10-30 |
1999-12-21 |
Pflizer Inc. |
Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
|
|
US5503846A
(en)
*
|
1993-03-17 |
1996-04-02 |
Cima Labs, Inc. |
Base coated acid particles and effervescent formulation incorporating same
|
|
US5895664A
(en)
*
|
1993-09-10 |
1999-04-20 |
Fuisz Technologies Ltd. |
Process for forming quickly dispersing comestible unit and product therefrom
|
|
US5965162A
(en)
*
|
1993-09-10 |
1999-10-12 |
Fuisz Technologies Ltd. |
Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom
|
|
US5576014A
(en)
*
|
1994-01-31 |
1996-11-19 |
Yamanouchi Pharmaceutical Co., Ltd |
Intrabuccally dissolving compressed moldings and production process thereof
|
|
GB9401894D0
(en)
*
|
1994-02-01 |
1994-03-30 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
|
US5869082A
(en)
*
|
1996-04-12 |
1999-02-09 |
Flemington Pharmaceutical Corp. |
Buccal, non-polar spray for nitroglycerin
|
|
WO1997038662A2
(en)
*
|
1996-04-12 |
1997-10-23 |
Flemington Pharmaceutical Corporation |
Buccal polar spray or capsule
|
|
US5955098A
(en)
*
|
1996-04-12 |
1999-09-21 |
Flemington Pharmaceutical Corp. |
Buccal non polar spray or capsule
|
|
US5804165A
(en)
*
|
1996-07-24 |
1998-09-08 |
Arnold; Michael J. |
Antiplaque oral composition
|
|
US6024981A
(en)
*
|
1997-04-16 |
2000-02-15 |
Cima Labs Inc. |
Rapidly dissolving robust dosage form
|
|
AU8977698A
(en)
*
|
1997-07-25 |
1999-02-16 |
Elan Corporation, Plc |
A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
|
|
US20050002867A1
(en)
*
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
|
US20030077228A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
|
|
US20040136914A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing ondansetron
|
|
US20040136913A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing sumatriptan
|
|
US20030095926A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
|
|
US20030095925A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
|
US20050281752A1
(en)
|
1997-10-01 |
2005-12-22 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
|
US20030077229A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
|
|
ES2293875T3
(es)
*
|
1997-10-01 |
2008-04-01 |
Novadel Pharma Inc. |
Aerosol bucal no polar.
|
|
US20040141923A1
(en)
*
|
1997-10-01 |
2004-07-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing alprazolam
|
|
US20040136915A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing atropine
|
|
US20030095927A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
|
|
US7632517B2
(en)
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
|
US20030077227A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
|
US20030190286A1
(en)
*
|
1997-10-01 |
2003-10-09 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
|
|
US20030082107A1
(en)
*
|
1997-10-01 |
2003-05-01 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
|
|
US20030185761A1
(en)
*
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
|
US6200604B1
(en)
*
|
1998-03-27 |
2001-03-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
|
US20030118645A1
(en)
*
|
1998-04-29 |
2003-06-26 |
Pather S. Indiran |
Pharmaceutical compositions for rectal and vaginal administration
|
|
US6350470B1
(en)
*
|
1998-04-29 |
2002-02-26 |
Cima Labs Inc. |
Effervescent drug delivery system for oral administration
|
|
US6576250B1
(en)
*
|
1998-03-27 |
2003-06-10 |
Cima Labs Inc. |
Pharmaceutical compositions for rectal and vaginal administration
|
|
US20030091629A1
(en)
*
|
1998-03-27 |
2003-05-15 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
|
US6197334B1
(en)
*
|
1998-04-13 |
2001-03-06 |
Donald V. Renda |
Lozenge and method of making
|
|
AUPP294698A0
(en)
*
|
1998-04-15 |
1998-05-07 |
Gray, Bruce |
Removable ball joint
|
|
EP1100508B8
(en)
*
|
1998-06-09 |
2004-01-07 |
Takeda Chemical Industries, Ltd. |
Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone and brotizolam for treating or preventing sleep disorders
|
|
US6368625B1
(en)
*
|
1998-08-12 |
2002-04-09 |
Cima Labs Inc. |
Orally disintegrable tablet forming a viscous slurry
|
|
EP2127642A3
(en)
*
|
1998-08-13 |
2010-02-24 |
Cima Labs, Inc. |
Microemulsions as solid dosage forms for oral administration
|
|
US20020098264A1
(en)
*
|
1998-11-27 |
2002-07-25 |
Cherukuri Subraman R. |
Medicated chewing gum delivery system for nicotine
|
|
US6344222B1
(en)
*
|
1998-09-03 |
2002-02-05 |
Jsr Llc |
Medicated chewing gum delivery system for nicotine
|
|
US6358060B2
(en)
*
|
1998-09-03 |
2002-03-19 |
Jsr Llc |
Two-stage transmucosal medicine delivery system for symptom relief
|
|
SE9803240D0
(sv)
*
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
A pharmaceutical composition having a rapid action
|
|
SE9803239D0
(sv)
*
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
Composition for the treatment of acute pain
|
|
US7815937B2
(en)
*
|
1998-10-27 |
2010-10-19 |
Biovail Laboratories International Srl |
Quick dissolve compositions and tablets based thereon
|
|
EP1005863A1
(en)
*
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
US7163705B2
(en)
*
|
1998-12-15 |
2007-01-16 |
Wm. Wrigley Jr. Company |
Coated chewing gum product and method of making
|
|
FR2787715B1
(fr)
*
|
1998-12-23 |
2002-05-10 |
Synthelabo |
Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables
|
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
ATE242241T1
(de)
*
|
1999-03-25 |
2003-06-15 |
Synthon Bv |
Imidazopyridinderivate und verfahren zu ihrer herstellung
|
|
US6210699B1
(en)
*
|
1999-04-01 |
2001-04-03 |
Watson Pharmaceuticals, Inc. |
Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
|
|
US6383471B1
(en)
*
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
US6395300B1
(en)
*
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US20040258750A1
(en)
*
|
1999-06-28 |
2004-12-23 |
Gerard Alaux |
Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
US6720001B2
(en)
*
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
US6264981B1
(en)
|
1999-10-27 |
2001-07-24 |
Anesta Corporation |
Oral transmucosal drug dosage using solid solution
|
|
US6753011B2
(en)
*
|
2000-01-14 |
2004-06-22 |
Osmotica Corp |
Combined diffusion/osmotic pumping drug delivery system
|
|
TWI220430B
(en)
*
|
2000-02-02 |
2004-08-21 |
Nat Science Council |
Method of synthesizing ferrocenyl-1,3-butadiene
|
|
US6586478B2
(en)
*
|
2000-02-22 |
2003-07-01 |
Cellegy Canada |
Methods and compositions for improving sleep
|
|
AU5066101A
(en)
*
|
2000-04-13 |
2001-10-30 |
Synthon B.V. |
Modified release formulations containing a hypnotic agent
|
|
CZ20023775A3
(cs)
*
|
2000-04-24 |
2003-10-15 |
Teva Pharmaceutical Industries Ltd. |
Zolpidem hemitartrát
|
|
AU2001261744A1
(en)
|
2000-05-19 |
2001-12-03 |
Npd Llc |
Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
|
|
US6264987B1
(en)
*
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
|
US7678387B2
(en)
*
|
2000-06-06 |
2010-03-16 |
Capricorn Pharma, Inc. |
Drug delivery systems
|
|
US6656492B2
(en)
|
2000-06-30 |
2003-12-02 |
Yamanouchi Pharmaceutical Co., Ltd. |
Quick disintegrating tablet in buccal cavity and manufacturing method thereof
|
|
US6375982B1
(en)
*
|
2000-07-05 |
2002-04-23 |
Capricorn Pharma, Inc. |
Rapid-melt semi-solid compositions, methods of making same and method of using same
|
|
JP3589167B2
(ja)
*
|
2000-08-28 |
2004-11-17 |
住友電装株式会社 |
コネクタ
|
|
US6733781B2
(en)
*
|
2000-12-06 |
2004-05-11 |
Wyeth |
Fast dissolving tablet
|
|
NZ527585A
(en)
*
|
2001-02-15 |
2005-04-29 |
Tanabe Seiyaku Co |
Tablets quickly disintegrated in oral cavity
|
|
US6692771B2
(en)
*
|
2001-02-23 |
2004-02-17 |
Cima Labs Inc. |
Emulsions as solid dosage forms for oral administration
|
|
US20020160043A1
(en)
*
|
2001-02-27 |
2002-10-31 |
Dennis Coleman |
Compositions and method of manufacture for oral dissolvable dosage forms
|
|
US7143054B2
(en)
*
|
2001-07-02 |
2006-11-28 |
The Procter & Gamble Company |
Assessment of communication strengths of individuals from electronic messages
|
|
US20030068356A1
(en)
*
|
2001-07-10 |
2003-04-10 |
Pather S. Indiran |
Sequential drug delivery systems
|
|
US6624162B2
(en)
*
|
2001-10-22 |
2003-09-23 |
Pfizer Inc. |
Imidazopyridine compounds as 5-HT4 receptor modulators
|
|
US7118765B2
(en)
*
|
2001-12-17 |
2006-10-10 |
Spi Pharma, Inc. |
Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
|
|
US6573011B1
(en)
*
|
2001-12-21 |
2003-06-03 |
Eastman Kodak Company |
Label with curl and moisture resistant protective layer
|
|
US20050147666A1
(en)
*
|
2002-03-06 |
2005-07-07 |
Kyowa Hakko Kogyo Co., Ltd. |
Tablets quickly disintegrating in oral cavity
|
|
US20030185884A1
(en)
*
|
2002-04-01 |
2003-10-02 |
Singh Nikhilesh Nihala |
Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpine
|
|
WO2003092591A2
(en)
*
|
2002-04-30 |
2003-11-13 |
Npd Llc |
Multi-phasic delivery via transmucosal absorption of antiemetic medicaments
|
|
WO2004037212A2
(en)
*
|
2002-10-24 |
2004-05-06 |
Sepracor, Inc. |
Compositions comprising zopiclone derivatives and methods of making and using the same
|
|
US20050038042A1
(en)
*
|
2002-11-15 |
2005-02-17 |
Jenet Codd |
Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
|
|
WO2004067004A1
(en)
*
|
2003-01-31 |
2004-08-12 |
Orexo Ab |
A rapid-acting pharmaceutical composition
|
|
US20040185097A1
(en)
*
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
|
EP1449525A1
(en)
*
|
2003-02-20 |
2004-08-25 |
Cross Chem Llc |
chewing gum in the form of multi-layer tablets
|
|
US20040265375A1
(en)
|
2003-04-16 |
2004-12-30 |
Platteeuw Johannes J. |
Orally disintegrating tablets
|
|
US20050042281A1
(en)
*
|
2003-08-21 |
2005-02-24 |
Singh Nikhilesh N. |
Compositions for delivering therapeutic agents across the oral mucosa
|
|
WO2005018565A2
(en)
*
|
2003-08-21 |
2005-03-03 |
Transoral Pharmaceuticals, Inc. |
Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof
|
|
EP1696959A2
(en)
*
|
2003-12-24 |
2006-09-06 |
Sepracor, Inc. |
Melatonin combination therapy for improving sleep quality
|
|
US7858121B2
(en)
|
2003-12-31 |
2010-12-28 |
Cima Labs, Inc. |
Effervescent oral fentanyl dosage form and methods of administering fentanyl
|
|
WO2005065319A2
(en)
|
2003-12-31 |
2005-07-21 |
Cima Labs Inc. |
Generally linear effervescent oral fentanyl dosage form and methods of administering
|
|
US7658945B2
(en)
*
|
2004-02-17 |
2010-02-09 |
Transcept Pharmaceuticals, Inc. |
Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
|
|
JP2008500288A
(ja)
*
|
2004-05-28 |
2008-01-10 |
イメイジノット ピーティーワイ エルティーディー |
経口治療用化合物の供給系
|
|
WO2006008636A2
(en)
*
|
2004-07-16 |
2006-01-26 |
Ranbaxy Laboratories Limited |
Processes for the preparation of zolpidem and its hemitartrate
|
|
US20060051413A1
(en)
*
|
2004-09-08 |
2006-03-09 |
Chow Sing S M |
Method of enhancing absorptions of transmucosal administration formulations
|
|
GB0423800D0
(en)
|
2004-10-27 |
2004-12-01 |
Orexo Ab |
New pharmaceutical formulations
|
|
JP4982065B2
(ja)
*
|
2005-09-26 |
2012-07-25 |
株式会社東芝 |
映像コンテンツ表示システム、映像コンテンツ表示方法及びそのプログラム
|
|
US20080145425A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Pliva Research & Development Limited |
Pharmaceutical composition of zolpidem
|